Digiceuticals Market size is poised to reach USD 115 Billion by the end of 2036, growing at a CAGR of 33% during the forecast period, i.e., 2024- 2036. In the year 2023, the industry size of digiceuticals was USD 5 Billion. The market expansion can be attributed to the rising incidence of various chronic conditions like high blood pressure, diabetes, and cardiovascular diseases.
Digiceuticals are used for continuous monitoring and management of diseases by keeping track of vital signs, such as blood pressure, heart rate, and glucose levels, and providing personalized advice on managing chronic diseases. According to World Health Organization, diabetes and renal disease caused an estimated 2 million deaths in 2019. As these numbers continue to rise there, it has created a demand for digital healthcare technology such as digiceuticals to conveniently access healthcare professionals, which can help ensure that patients receive timely advice and care.
Digiceuticals provide individualized treatment regimens and treatments based on personal health information. Rising consumer awareness and need for individualized healthcare have boosted demand for Digiceuticals. Consumers are taking a more proactive approach to maintaining their health and looking for individualized solutions.
Growth Drivers
Challenges
Base Year |
2023 |
Forecast Year |
2024-2036 |
CAGR |
~33% |
Base Year Market Size (2023) |
~ USD 5 Billion |
Forecast Year Market Size (2036) |
~ USD 115 Billion |
Regional Scope |
|
Use (Smart phone, Watches, Medical Device System)
In digiceuticals market, smartphones segment is poised to hold more than 38% share by 2036. The segment growth is on the account of the increasing number of smartphone users in the world. For instance, in 2021, the number of mobile users worldwide stood at 7.1 billion. Smartphone users are increasingly using their phones to get health information, track their data, and plan appointments.
Furthermore, smartphones are rapidly being outfitted with health sensors such as accelerometers, gyroscopes, heart rate monitors, and even pulse oximeters, allowing users to monitor vital indications like heart rate and blood pressure. The segment’s rapid expansion is on the account of these factors.
Application (Diabetes Management, Substance Abuse, Pulmonary Diseases, Alcohol and Smoking Addiction, Neurological Disorders)
In digiceuticals market, diabetes management segment is estimated to capture over 29% revenue share by 2036. The segment growth can be attributed to the increasing prevalence of diabetes, growing awareness about preventive measures, and rising government initiatives to provide better healthcare facilities for diabetic patients. According to IDF projections it is estimated that by 2045 around 783 million adults, which is one in eight individuals will live with diabetes. This represents a 46% increase. It is interesting to note that over 90% of diabetes patients are specifically diagnosed with type 2 diabetes.
Diabetes management requires regular monitoring of blood sugar levels and adjustment of medication accordingly. Digiceuticals allow people with diabetes to track their blood sugar levels remotely and alert them if they need to adjust their medication.
Our in-depth analysis of the digiceuticals market includes the following segments:
Use |
|
Application |
|
Distribution Channel |
|
North America Market Forecast
By 2036, North America region is expected to hold more than 31% digiceuticals market share. The market growth in the region is also expected on account of the rising prevalence of chronic diseases, the rising adoption of digital health technologies, the increasing investments by venture capitalists in healthcare innovation, and the growing acceptance of digital therapeutics by healthcare professionals.
Moreover, the Food and Drug Administration has approved a growing number of digiceuticals, as treatments that doctors can prescribe. This also enables these treatments to be covered by health plans. An example of an FDA approved app is reSET O which offers therapy sessions for individuals struggling with opioid addiction. These sessions are conducted under clinician supervision. ReSET O is currently used in substance abuse facilities throughout the country.
APAC Market Analysis
By 2036, Asia Pacific region in digiceuticals market is anticipated to capture over 27% revenue share. Rising prevalence of lifestyle-related diseases, growing awareness about the importance of preventive healthcare, and increasing government initiatives to promote the use of digital health solutions are the main factors driving the growth of the Asia Pacific market.
For instance, in May 2020 the National Health Commission (NHC) of the People's Republic of China urged governments to create their own online regulatory systems. These platforms would monitor and supervise online healthcare providers as well as expedite the entry of internet-based hospitals into the digiceuticals market.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?